| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 116.16B | — |
| Operating expense | — | — |
| Net income | 24.15B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ON4.MU returned -77.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -158.3% |
| 1 year | -77.4% |
| 5 years | -86.5% |
| 10 years | +125312557565.3% |
| All-time high | €40.11 (Apr 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ON4.MU would be worth today ›Yes. Ono Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.22 per share on Mar 30, 2026. The dividend yield is 3.29%.
Ono Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Ono Pharmaceutical Co., Ltd. has a market cap of 6.23B EUR, based on the latest quote.
Ono Pharmaceutical Co., Ltd. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
